These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 10614815

  • 1. Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin.
    Bernkop-Schnürch A, Kirchmayer R, Kratzel M.
    J Drug Target; 1999; 7(1):55-63. PubMed ID: 10614815
    [Abstract] [Full Text] [Related]

  • 2. Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.
    Bernkop-Schnürch A, Krauland A, Valenta C.
    J Drug Target; 1998; 6(3):207-14. PubMed ID: 9888307
    [Abstract] [Full Text] [Related]

  • 3. Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues.
    Kratzel M, Hiessböck R, Bernkop-Schnürch A.
    J Med Chem; 1998 Jun 18; 41(13):2339-44. PubMed ID: 9632367
    [Abstract] [Full Text] [Related]

  • 4. Anionic mucoadhesive polymers as auxiliary agents for the peroral administration of (poly)peptide drugs: influence of the gastric juice.
    Bernkop-Schnürch A, Gilge B.
    Drug Dev Ind Pharm; 2000 Feb 18; 26(2):107-13. PubMed ID: 10697747
    [Abstract] [Full Text] [Related]

  • 5. Simplified pepstatins: synthesis and evaluation of N-terminally modified analogues.
    Kratzel M, Schlichtner B, Kirchmayer R, Bernkop-Schnürch A.
    J Med Chem; 1999 Jun 03; 42(11):2041-5. PubMed ID: 10354412
    [Abstract] [Full Text] [Related]

  • 6. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
    Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schöffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Esposito P, Huck C.
    J Control Release; 2005 Aug 18; 106(1-2):26-33. PubMed ID: 15939501
    [Abstract] [Full Text] [Related]

  • 7. Thiomers: potential excipients for non-invasive peptide delivery systems.
    Bernkop-Schnürch A, Krauland AH, Leitner VM, Palmberger T.
    Eur J Pharm Biopharm; 2004 Sep 18; 58(2):253-63. PubMed ID: 15296953
    [Abstract] [Full Text] [Related]

  • 8. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK, Jain SK.
    J Pharm Pharm Sci; 2003 Sep 18; 6(1):33-66. PubMed ID: 12753729
    [Abstract] [Full Text] [Related]

  • 9. Design and in vivo evaluation of an oral delivery system for insulin.
    Marschütz MK, Caliceti P, Bernkop-Schnürch A.
    Pharm Res; 2000 Dec 18; 17(12):1468-74. PubMed ID: 11303955
    [Abstract] [Full Text] [Related]

  • 10. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery.
    Thompson CJ, Tetley L, Cheng WP.
    Int J Pharm; 2010 Jan 04; 383(1-2):216-27. PubMed ID: 19766178
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
    Kafedjiiski K, Jetti RK, Föger F, Hoyer H, Werle M, Hoffer M, Bernkop-Schnürch A.
    Int J Pharm; 2007 Oct 01; 343(1-2):48-58. PubMed ID: 17544606
    [Abstract] [Full Text] [Related]

  • 12. Design and in vitro evaluation of a mucoadhesive oral delivery system for a model polypeptide antigen.
    Marschütz MK, Puttipipatkhachorn S, Bernkop-Schnürch A.
    Pharmazie; 2001 Sep 01; 56(9):724-9. PubMed ID: 11593993
    [Abstract] [Full Text] [Related]

  • 13. The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery.
    Thompson CJ, Tetley L, Uchegbu IF, Cheng WP.
    Int J Pharm; 2009 Jul 06; 376(1-2):46-55. PubMed ID: 19375489
    [Abstract] [Full Text] [Related]

  • 14. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP, Roberts NB.
    Clin Sci (Lond); 2001 Apr 06; 100(4):411-7. PubMed ID: 11256980
    [Abstract] [Full Text] [Related]

  • 15. Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin.
    Guggi D, Krauland AH, Bernkop-Schnürch A.
    J Control Release; 2003 Sep 19; 92(1-2):125-35. PubMed ID: 14499191
    [Abstract] [Full Text] [Related]

  • 16. Coating polymers for colon specific drug delivery: a comparative in vitro evaluation.
    Sinha VR, Kumria R.
    Acta Pharm; 2003 Mar 19; 53(1):41-7. PubMed ID: 14769251
    [Abstract] [Full Text] [Related]

  • 17. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 18. Peanut protein allergens: gastric digestion is carried out exclusively by pepsin.
    Kopper RA, Odum NJ, Sen M, Helm RM, Steve Stanley J, Wesley Burks A.
    J Allergy Clin Immunol; 2004 Sep 24; 114(3):614-8. PubMed ID: 15356566
    [Abstract] [Full Text] [Related]

  • 19. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM.
    Crit Rev Ther Drug Carrier Syst; 1994 Sep 24; 11(2-3):119-60. PubMed ID: 7600586
    [Abstract] [Full Text] [Related]

  • 20. Enhanced permeability of the urinary bladder wall: the role of polymer charge.
    Kerec Kos M, Bogataj M, Mrhar A.
    Pharmazie; 2009 Apr 24; 64(4):232-7. PubMed ID: 19435140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.